PubMed Health⌕ Search

Biomedical subjects

Márta Ujpál

Publications and source records attributed to Márta Ujpál.

8 recordsLinked to original sources

[Correlations of insulin resistance and neoplasms].

Insulin resistance is a worldwide risk factor for the two most dangerous human disease groups; namely, for cardiovascular lesions and malignancies. The insulin resistance syndrome have five basic criteria: hyperglycemia, visceral obesity, elevated serum triglyceride level, low HDL-cholesterol level (dyslipidemia) and hypertension. Each of these criteria alone are risk factors for cancer, and they mean together a multiple risk. Insulin resistance of the liver, skeletal muscles, and fatty tissue leads to a reactive hyperinsulinemia by the increased secretory activity of the beta-cells. Insulin has diverse metabolic effects, and at the same time is a growth factor. It enhances the production and mitogenic activity of other, insulin-like growth factors, and leads to pathological cell proliferation. In the uncompensated phase of insulin resistance hyperglycemia appears, which promotes tumor genesis by several pathways. The elevated serum glucose level is advantageous for the increased DNA synthesis of the tumor cells. It provokes deliberation of free radicals, which will cause derangement of both the DNA and the enzymes having a role in the repair mechanisms. Hyperglycemia leads to a nonenzymatic glycation of protein structures, and the glycated products enhance the deliberation of free radicals, cytokines and growth factors. Insulin resistance means an enhanced risk for breast, pancreas, liver, colon, bladder, prostate and oral cavity cancers. The moderately increased fasting glucose level is also a risk factor for breast, stomach and colon cancers, even without manifestation of type 2 diabetes. Insulin resistance promotes tumor progression as well. In cancer patients with hyperglycemia or type 2 diabetes, the rate of tumor recurrence, metastatic spread and fatal outcome is higher as compared with the tumor patients without metabolic disease. The correlation between insulin resistance and tumor promotion reveals new possibilities in the prevention and treatment of cancer. The healthy diet, physical activity and weight loss increase insulin sensitivity, and decrease the risk for both cardiovascular diseases and malignancies.

Aging↗

[Epidemiological correlations of insulin resistance and salivary gland tumors].

INTRODUCTION: The metabolic syndrome develops on the basis of peripheral insulin resistance. It is a continuously progressing metabolic disorder, which concludes finally into serious diseases. Type-2 diabetes, cardiovascular disease and--according to the recent literature--malignancies are the most important consequences. A well-known fact, that metabolic disorders; such as diabetes and obesity, can deeply influence the structure and function of the salivary glands. Considering these data, the question arises; is there any correlation among insulin resistance, type-2 diabetes and salivary gland tumors? AIMS: A retrospective epidemiological examination was performed to analyze the correlations between salivary gland tumors and insulin resistance states (type-2 diabetes and metabolic syndrome). METHODS: Data of 438 patients were analyzed in the Maxillofacial Surgery Clinic of the Semmelweis University. In 224 cases salivary gland tumors were surgically removed. In 214 control cases, bone replacement, or artificial root implantation was the intervention. Known, treated and newly diagnosed diabetic cases were included in the DM group. Cases exhibiting at least 3 of the 5 criteria of the metabolic syndrome composed the MS group. The remaining cases were included in the non-DM/non-MS group. The frequencies of cardiovascular diseases and of primary tumors at other sites were registered in the different groups. RESULTS: Type-2 diabetes was significantly more frequent in the tumorous group (22.8%) than in the controls (6.5%) (p < 0.001). Similarly, the metabolic syndrome was much more frequent among the tumorous cases (31.3%) as compared with the control group (7.9%) (p < 0.001). The rate of cardiovascular diseases was significantly higher in the DM and MS subgroups of the tumorous patients (15.6% and 17.1%, respectively) as compared with the controls (5.6%) (p < 0.05 and p < 0.01, respectively). The rate of primary tumors of other sites, as concerns both tumors overall and malignancies, was significantly higher among the salivary gland tumorous cases (17.8% and 8.9%, respectively) than among the controls (8.4% and 2.8%, respectively) (p < 0.01 and p < 0.05, respectively). In the DM and MS subgroups of the tumorous cases the rate of primary tumors was even higher (28.0% and 22.9%, respectively), however, that for the non-DM/non-MS subgroup was similar to that for controls (9.7). CONCLUSIONS: Considering the present results and the literature data a better control of insulin resistant states seems to be necessary, not only to reduce the cardiovascular risk, but also to prevent tumor promotion.

Adult↗

[Diabetes mellitus and tumors of the oral cavity--epidemiologic correlations].

INTRODUCTION AND AIMS: Numerous publications have already demonstrated that diabetes mellitus (DM) is a risk factor for the development of periodontal diseases and various inflammatory lesions in the oral mucosa. A possible correlation between DM and oral premalignancies and tumors was examined in this study, as no literature data are available concerning this problem. METHODS: Stomato-oncological screening was carried out on 200 DM patients in the medical departments: The lesions found were classified in three groups: inflammatory lesions, benign tumors and precancerous lesions. Benign tumors were found in 14.5%, and precancerous lesions in 8% of diabetics. Earlier Hungarian screening studies indicated lower frequency of these lesions in the general population. A retrospective DM screening of 610 inpatients with histologically confirmed oral malignancies was also performed. The control group comprised 574 complaint- and tumor-free adults. Fasting blood glucose levels were determined in both groups, and the tumor location was registered in the cancer patients. RESULTS: In the group of the oral cancer patients, DM was present in 14.6% and an elevated blood glucose level in 9.7%. These values are significantly higher than those for the tumor-free control group (p < 0.01). The gingival and labial tumor location was significantly more frequent among diabetic cancer patients than in the non-diabetic group (p < 0.01). CONCLUSION: The combination of DM and smoking means a higher risk for oral precancerous lesions and malignancies. DM may be a risk factor for oral premalignancies and tumors.

Adult↗

Diabetes and oral tumors in Hungary: epidemiological correlations.

OBJECTIVE: Numerous publications have already demonstrated that diabetes is a risk factor for the development of periodontal diseases and various inflammatory lesions in the oral mucosa. A possible correlation between diabetes and oral premalignancies and tumors was examined in this study, as no literature data are available concerning this problem. RESEARCH DESIGN AND METHODS: Stomato-oncological screening was carried out on 200 diabetic patients in the medical departments; the control group included 280 adult dentistry outpatients. The lesions found were classified into three groups: inflammatory lesions, benign tumors, and precancerous lesions. A retrospective diabetes screening of 610 inpatients with histologically confirmed oral malignancies was also performed. The control group comprised 574 complaint- and tumor-free adults. Fasting blood glucose levels were determined in both groups, and the tumor location was registered in the cancer patients. RESULTS: Benign tumors were found in 14.5% and precancerous lesions in 8% of diabetic patients. In the control group these values were significantly lower, at 6.4 and 3.2%, respectively (P>0.01). Earlier Hungarian screening studies indicated similar frequency of these lesions in the general population. The proportion of oral cavity lesions was higher among diabetic patients compared with that of the control patients. In the oral cancer patient group, diabetes was present in 14.6% and an elevated blood glucose level in 9.7%. These values are significantly higher than those for the tumor-free control group (P<0.01). The gingival and labial tumor location was significantly more frequent among diabetic cancer patients than in the nondiabetic group (P<0.01). The combination of diabetes and smoking means a higher risk for oral precancerous lesions and malignancies. CONCLUSIONS: Diabetes may be a risk factor for oral premalignancies and tumors.

Comorbidity↗

[Stomato-oncological screening in diabetic patients].

The data of the literature suggest that studies have not been performed to date on possible correlations between diabetes and precancerous states and tumors in the oral cavity. Internationally, only one investigation appears to have dealt with the incidence of leukoplakia among diabetics. In the present work, stomato-oncological screening was performed on 200 treated diabetics. Precancerous lesions were found in 8%, and benign lesions in 14.5%. Comparison with earlier Hungarian screening studies indicated that benign and precancerous lesions occur with greater frequency among diabetics than in the average population. The proportion of oral cavity lesions is higher among diabetics of type 2 than among those of type 1. The combination of diabetes mellitus and smoking means an enhanced risk from the aspect of precancerosis of the oral cavity.

Adult↗

[Incidence of diabetes mellitus in patients with malignant tumors of the oral cavity].

Diabetes mellitus affects 5% of the population of Hungary. Its complications in the oral cavity include parodontosis and changes in the oral mucosa (leukoplakia, lichen oris and glossitis). The incidence of leukoplakia (the most frequent precancerous state in the oral cavity) is 2.2% in the normal population, 6.2% among diabetics, and 11.5% among diabetic who smoke. The various forms of leukoplakia in the oral cavity become malignant in 5-20% of the cases, while the erosive, ulcerative lesions do so in 15-20% of the cases. These data led us to examine the blood glucose levels in 318 patients with histologically confirmed malignant tumours in the oral cavity. Diabetes mellitus was found in 56 of them (17.5%), the blood glucose level being elevated in 31 cases (9.75%). The fact that the incidence of diabetes mellitus among these patients was more than 3 times higher than that for the normal population demonstrates that further studies should be performed on the connection between diabetes mellitus and malignant tumours in the oral cavity.

Adult↗

[Gardner syndrome. Case reports].

The authors discuss 3 cases of Gardner-syndrome, outlining malignized large intestine polyposis, multiplex osteomas and the different skin tumours as the main features. The earliest symptoms suspecting the clinical picture are usually dental and/or mandibular lesions and draw the attention to the highly malignant polyposis.

Adult↗